Abstract:ObjectivesUsing quantitative coronary angiography (QCA), optical coherence tomography (OCT), histomorphometry, and pharmacokinetics, this study tried to evaluate the safety and efficacy of Biomagic rapamycin-eluting bioabsorbable scaffold (BVS) in non-atherosclerotic porcine coronary arteries.BackgroundBiomagic BVS is a new generation of thin-strut bioabsorbable scaffold. We conducted comparative study detailing pathological response, safety and efficacy of Biomagic BVS and the Firebird2 rapamycin-eluting cobalt-based alloy stent (DES) in a porcine coronary artery model. The animals were followed up at 14 days, 1, 3, 6, 12, 18, 24, 30, 36, 42, 48, 54, and 60 months after stent implantation.MethodsA total of 143 devices (95 Biomagic and 48 Firebird2) were implanted in 2 or 3 main coronary arteries of 76 nonatherosclerotic swine and examined by QCA, OCT, light microscopy, and pharmacokinetics analyses at various time points.ResultsVascular responses to Biomagic and Firebird2 were largely comparable at all time points, with struts being sequestered within the neointima. The degree of inflammation of both devices was mild to moderate, although the Biomagic score was higher at 14 days to 24 months. However, there was no statistical difference between the two groups except 14 days. At each follow-up time point, the percentage of area stenosis in the Biomagic group was greater than that in the Firebird 2 group, but there was no statistical difference between the two groups at 3 and 12 months. The extent of fibrin deposition was similar between Biomagic and Firebird2, which peaked at 1 month and decreased rapidly thereafter. Pharmacokinetic study showed that coronary tissue sirolimus concentration remained above 2 ng/mg of tissue at 28 day. Histomorphometry showed expansile remodeling of Biomagic-implanted arteries starting after 12 months, and lumen area was significantly greater in Biomagic than Firebird2 at 36 and 42 months. These changes correlated with dismantling of Biomagic seen after 12 months. OCT images confirmed that degradation of Biomagic was complete by 36 months.ConclusionsBiomagic demonstrates comparable long-term safety to Firebird2 in porcine coronary arteries with mild to moderate inflammation. Although Biomagic was associated with greater percent stenosis relative to Firebird2 within 36 months, expansile remodeling was observed after 12 months in Biomagic with significantly greater lumen area at ≥36 months. Scaffold resorption is considered complete at 36 months.

Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary artery

Long-Term in Vivo Corrosion Behavior, Biocompatibility and Bioresorption Mechanism of A Bioresorbable Nitrided Iron Scaffold

Long-Term Efficacy, Safety and Biocompatibility of a Novel Sirolimus Eluting Iron Bioresorbable Scaffold in a Porcine Model

Design and Characterization of a Novel Biocorrodible Iron-Based Drug-Eluting Coronary Scaffold

Three‐year Clinical Outcomes of the Novel Sirolimus‐eluting Bioresorbable Scaffold for the Treatment of De Novo Coronary Artery Disease: A Prospective Patient‐level Pooled Analysis of NeoVas Trials

In vivo degradation and endothelialization of an iron bioresorbable scaffold

Degradation of a novel magnesium alloy-based bioresorbable coronary scaffold in a swine coronary artery model

Characterization and in Vivo Evaluation of a Bio-Corrodible Nitrided Iron Stent

PDLLA-Zn-nitrided Fe Bioresorbable Scaffold with 53-Μm-thick Metallic Struts and Tunable Multistage Biodegradation Function

Long-term in vivo study of biodegradable Zn-Cu stent: A 2-year implantation evaluation in porcine coronary artery.

Biosafety and Efficacy Evaluation of a Biodegradable Zn-Cu-Mn Stent: A Long-Term Study in Porcine Coronary Artery

A Head to Head Comparison of XINSORB Bioresorbable Sirolimus-Eluting Scaffold Versus Metallic Sirolimus-Eluting Stent: 180 Days Follow-Up in a Porcine Model

Safety of a novel biodegradable stent implanted in the coronary artery in a porcine model

Long-Term Safety of an Everolimus-Eluting Bioresorbable Vascular Scaffold and the Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

[Research Progress of Bioresorbable Scaffold].

Long-Term Efficacy of Biodegradable Metal-Polymer Composite Stents after the First and the Second Implantations into Porcine Coronary Arteries

Evaluation of Long-Term Inflammatory Responses after Implantation of a Novel Fully Bioabsorbable Scaffold Composed of Poly-L-lactic Acid and Amorphous Calcium Phosphate Nanoparticles

Five-year Comparative Study of Thin-Strut Rapamycin-Eluting Bioabsorbable Scaffold with Metallic Drug-Eluting Stent in Porcine Coronary Artery

A Novel High Nitrogen Nickel-free Coronary Stents System: Evaluation in a Porcine Model

A biodegradable metal‐polymer composite stent safe and effective on physiological and serum‐containing biomimetic conditions

Effect of Novel Fully Biodegradable Drug-Eluting Scaffold Implantation on Endothelial Repairing in Porcine Coronary Model